Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue,
and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). Objectives …

Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS).
Objective: The objective of this review is to estimate the incidence and prevalence of …

Multiple sclerosis (MS) is a progressive disease of the CNS that is characterised by
widespread lesions in the brain and spinal cord. MS results in motor, cognitive, and …

Several studies have reported high rates of depression in multiple sclerosis (MS) with a
lifetime prevalence of∼ 50% and an annual prevalence of 20% not uncommon. Concern …

This review summarizes the existing knowledge regarding the effects of physical exercise in
patients suffering from multiple sclerosis (MS). Furthermore, recommendations are given …

Quality of Life (QOL) is impaired in multiple sclerosis (MS) in part due to physical disability.
MS-associated fatigue (MSF) and depression (MSD) are common and treatable features of …

Objective To assess prevalence rates and clinical correlates of anxiety disorders in patients
with multiple sclerosis (MS). Methods Demographic and neurological data were collected on …

Multiple Sclerosis (MS) is a chronic neurological disease which poses significant
psychological adjustment challenges. The purpose of this systematic review was to identify …

Objectives–In a series of 504 patients with multiple sclerosis (MS), quality of life (QOL) and
its main clinical and demographic determinants were assessed in comparison with healthy …

High levels of depressive and anxiety symptoms have been reported by individuals with
multiple sclerosis (MS). This study examined the associations between resilience, self …